Atossa Therapeutics, Inc. (ATOS)
NASDAQ·Healthcare·Biotechnology
$5.52
+1.28%
Mkt Cap $39.35M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$1.14 | -$1.19 | -4.62% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.05 | -$1.05 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.06 | -$0.07 | -16.67% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.05 | -$0.05 | +0.00% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.07 | -$0.05 | +28.57% | — | — |
| Q2 2024 Apr 1, 2024 | — | $18.00K | — | -$0.05 | -$0.06 | -20.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.07 | -$0.05 | +28.57% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.05 | -$0.04 | +20.00% | — | — |
| Q1 2022 Feb 28, 2022 | — | — | — | -$0.04 | -$0.04 | -11.11% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.04 | -$0.04 | -11.11% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$0.04 | -$0.06 | -71.43% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$0.05 | -$0.04 | +20.00% | — | — |